reversetaxman, sounds to me like the market had already anticipated this event and the value was reflected in the current stock price. I noticed that the drug YMI licensed had been previously licensed in India, and now it was being licensed in Japan. No big deal. I don't think we can compare YMI and BOCX based on this event alone.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.